Atlas Venture Life Science Advisors, LLC has filed its 13F form on August 12, 2025 for Q2 2025 where it was disclosed a total value porftolio of $455 Million distributed in 11 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Kymera Therapeutics, Inc. with a value of $214M, Dyne Therapeutics, Inc. with a value of $86.9M, Third Harmonic Bio, Inc. with a value of $56.5M, Vigil Neuroscience, Inc. with a value of $46.4M, and Day One Biopharmaceuticals, Inc. with a value of $41.8M.

Examining the 13F form we can see an increase of $113M in the current position value, from $341M to 455M.

Below you can find more details about Atlas Venture Life Science Advisors, LLC portfolio as well as his latest detailed transactions.

Portfolio value $455 Million
Healthcare: $455 Million

Stock Holdings Table Companies Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 11
  • Current Value $455 Million
  • Prior Value $341 Million
  • Filing
  • Period Q2 2025
  • Filing Date August 12, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Atlas Venture Life Science Advisors, LLC Portfolio

Follow Atlas Venture Life Science Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Venture Life Science Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Venture Life Science Advisors, LLC with notifications on news.